How to diagnose and treat pulmonary embolism

Event : ESC Congress 2018

• Session : Adult congenital heart disease, pulmonary hypertension and pulmonary embolism: review, update, and State of the Art in 2018
• Speaker : M Lankeit (Berlin,DE)

Outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension - a German single centre two-year experience

Event : ESC Congress 2017

• Session : CTEPH: Catheter-directed and surgical therapy
• Speaker : M Lankeit (Berlin,DE)

Risk factors for chronic thromboembolic pulmonary hypertension - importance of thyroid disease and treatment

Event : ESC Congress 2017

• Session : Best Posters in pulmonary hypertension
• Speaker : M Lankeit (Berlin,DE)

Screening for chronic thromboembolic pulmonary hypertension after pulmonay embolism: for whom and how?

Event : ESC Congress 2017

• Session : Open questions in pulmonary vascular diseases
• Speaker : M Lankeit (Berlin,DE)

• Joint with the European Respiratory Society

A patient with low-risk pulmonary embolism - Or was it intermediate risk? - Clinical case

Event : ESC Congress 2016

• Session : Tough calls in pulmonary embolism
• Speaker : M Lankeit (Berlin,DE)

A patient with pulmonary embolism and cancer

Event : ESC Congress 2016

• Session : Pulmonary embolism: facing the limits of evidence
• Speaker : M Lankeit (Berlin,DE)

Combination with clinical parameters optimises the prognostic value of heart-type fatty acid-binding protein (H-FABP) in normotensive patients with pulmonary embolism

Event : ESC Congress 2014

• Session : New insights in acute pulmonary embolism
• Speaker : M Lankeit (Berlin,DE)

Angiopoietin-2 - a novel biomarker for risk stratification of acute pulmonary embolism

Event : ESC Congress 2013

• Session : Acute pulmonary embolism
• Speaker : M Lankeit (Berlin,DE)

Long-term follow-up after acute pulmonary embolism - impact of markers of acute prognosis.

Event : ESC Congress 2013

• Session : Acute pulmonary embolism
• Speaker : M Lankeit (Berlin,DE)